Search - tctmd.com

Displaying 141 - 160 of 176

Sort: Relevancy | Date

Micra Leadless Pacemaker Performs Well Through 5 Years

News Daily News

Micra Leadless Pacemaker Performs Well Through 5 Years

March 06, 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Presentation THT 2024

RECOVER-HF Pilot Study: Synchronized Diaphragmatic Stimulation for HFrEF Therapy

Presenter: Marat Fudim

March 05, 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presentation THT 2024

Novel Strategies in mRNA Therapeutics for Heart Failure

Presenter: John Cooke

March 05, 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

AAV9 Expression of Junctophilin to Treat HF

Presentation THT 2024

AAV9 Expression of Junctophilin to Treat HF

Presenter: Long-Sheng Song

March 05, 2024

Lessons Learned From Conducting Gene Therapy Studies

Presentation THT 2024

Lessons Learned From Conducting Gene Therapy Studies

Presenter: Barry Greenberg

March 05, 2024

Pericut: Pericardiotomy as a Therapy for HFpEF

Presentation THT 2024

Pericut: Pericardiotomy as a Therapy for HFpEF

Presenter: Barry Borlaug

March 04, 2024

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

March 04, 2024

High Lp(a) Levels Harmful in Patients With and Without ASCVD

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

One in Three Overweight MI Patients May Benefit From Semaglutide

News Daily News

One in Three Overweight MI Patients May Benefit From Semaglutide

February 26, 2024

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

February 23, 2024

Niacin, When Broken Down by the Body, Can Spur Inflammation

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

February 22, 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

News Conference News ISC 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

February 16, 2024

AI-Based System Boosts Quality of Stroke Care and Reduces Events

News Conference News ISC 2024

AI-Based System Boosts Quality of Stroke Care and Reduces Events

February 16, 2024

TriClip panel FDA

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

Assisted Reproductive Technology Linked to Higher Stroke Risk

News Conference News ISC 2024

Assisted Reproductive Technology Linked to Higher Stroke Risk

February 07, 2024

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

Injectable Semaglutide Shortage Forces Physicians to Pivot

News Daily News

Injectable Semaglutide Shortage Forces Physicians to Pivot

February 05, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.